Skip to main content
Kevin Kalinsky, MD, Oncology, Atlanta, GA, New York-Presbyterian Hospital

KevinMKalinskyMDMS

Oncology Atlanta, GA

Hematologic Oncology

Associate Professor of Medicine, Winship Cancer Institute at Emory University

Dr. Kalinsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kalinsky's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2009
  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 2002 - 2005
  • Medical University of South Carolina College of Medicine
    Medical University of South Carolina College of MedicineClass of 2002

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2020 - 2023
  • NY State Medical License
    NY State Medical License 2008 - 2023
  • MA State Medical License
    MA State Medical License 2006 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Capivasertib in Patients with an AKT1 E17K-Mutated Tumor  
    Kevin Kalinsky, Edith P Mitchell, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology

Lectures

  • Enhancing Checkpoint Inhibitors in Triple-Negative Breast Cancer. Breast Cancer Immunotherapy: Can We Crack the Code? 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Phase IB trial of ACY-1215 (Ricolinostat) combined with nab-paclitaxel in metastatic breast cancer. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Dr. Kalinsky on Clinical Impact of Atezolizumab Combo in TNBC
    Dr. Kalinsky on Clinical Impact of Atezolizumab Combo in TNBCJanuary 31st, 2020
  • Despite Advances, Unmet Need Remains in TNBC
    Despite Advances, Unmet Need Remains in TNBCFebruary 3rd, 2020
  • Unmet Needs Remain in TNBC Treatment
    Unmet Needs Remain in TNBC TreatmentFebruary 3rd, 2020
  • Join now to see all

Hospital Affiliations